Rivaroxaban, a novel, oral, direct Factor Xa inhibitor, enhanced the antithrombotic effects of clopidogrel and acetylsalicylic acid in rats

被引:0
|
作者
Perzborn, E. [1 ]
Fischer, E. [1 ]
Lange, U. [1 ]
机构
[1] Bayer HealthCare, Cardiovasc Res, Wuppertal, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:189 / 189
页数:1
相关论文
共 50 条
  • [1] Concomitant administration of low-dose rivaroxaban - an oral, direct Factor Xa inhibitor - with clopidogrel and acetylsalicylic acid enhances antithrombotic efficacy in rats
    Perzborn, E.
    Fischer, E.
    Lange, U.
    Harwardt, M.
    EUROPEAN HEART JOURNAL, 2009, 30 : 331 - 332
  • [2] Enhanced antithrombotic effects with the combination of rivaroxaban - a novel, oral, direct factor Xa inhibitor and clopiclogrel, in animal models
    Perzborn, E.
    Fischer, E.
    Lange, U.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 81 - 81
  • [3] Rivaroxaban: A Novel, Oral, Direct Factor Xa Inhibitor
    Abrams, Paris J.
    Emerson, Christopher R.
    PHARMACOTHERAPY, 2009, 29 (02): : 167 - 181
  • [4] Effects of rivaroxaban, a novel, oral, direct Factor Xa inhibitor, on coagulation assays
    Samama, M. M.
    Fem, L. L.
    Guinet, C.
    Perzborn, E.
    Martinoli, J.
    Depasse, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 693 - 693
  • [5] Effects of rivaroxaban, a novel, oral, direct factor Xa inhibitor, on coagulation assays
    Samama, M. M.
    Le Flem, L.
    Guinet, C.
    Perzborn, E.
    Martinoli, J-L
    Depasse, F.
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 : 35 - 36
  • [6] Effects of the Novel, Oral, Direct Factor Xa Inhibitor Rivaroxaban on Coagulation Assays
    Samama, Meyer Michel
    Le Flem, Lena
    Guinet, Celine
    Perzborn, Elisabeth
    Martinoli, Jean-Luc
    Depasse, Francois
    BLOOD, 2008, 112 (11) : 1041 - 1042
  • [7] Antithrombotic effects enhanced with the combination of rivaroxaban, clopiclogrel and acetylsalicylic acid in rats
    Perzborn, E.
    Fischer, E.
    Lange, U.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 81 - 81
  • [8] Rivaroxaban: An oral direct inhibitor of factor Xa
    Gulseth, Michael P.
    Michaud, Jessica
    Nutescu, Edith A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (16) : 1520 - 1529
  • [9] Rivaroxaban, an oral direct factor Xa inhibitor
    Piccini, Jonathan P.
    Patel, Manesh R.
    Mahaffey, Kenneth W.
    Fox, Keith A. A.
    Califf, Robert M.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (06) : 925 - 937
  • [10] Co-administration of rivaroxaban - a novel, oral, direct Factor Xa inhibitor - and clopidogrel in healthy subjects
    Kubitza, D.
    Becka, M.
    Mueck, W.
    Zuehlsdorf, M.
    EUROPEAN HEART JOURNAL, 2007, 28 : 189 - 189